Repligen (RGEN) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.35% |
| Dec 31, 2025 | -0.75% |
| Sep 30, 2025 | 0.49% |
| Jun 30, 2025 | -1.29% |
| Mar 31, 2025 | -9.89% |
| Dec 31, 2024 | -292.86% |
| Sep 30, 2024 | -19.08% |
| Jun 30, 2024 | -6.73% |
| Mar 31, 2024 | -16.37% |
| Dec 31, 2023 | -15.78% |
| Sep 30, 2023 | 28.69% |
| Jun 30, 2023 | 48.52% |
| Mar 31, 2023 | 52.92% |
| Dec 31, 2022 | 31.96% |
| Sep 30, 2022 | 53.97% |
| Jun 30, 2022 | 42.66% |
| Mar 31, 2022 | 72.86% |
| Dec 31, 2021 | 42.07% |
| Sep 30, 2021 | 96.10% |
| Jun 30, 2021 | 56.40% |
| Mar 31, 2021 | 96.29% |
| Dec 31, 2020 | 120.45% |
| Sep 30, 2020 | 41.80% |
| Jun 30, 2020 | 34.43% |
| Mar 31, 2020 | 27.36% |
| Dec 31, 2019 | 16.39% |
| Sep 30, 2019 | 2.50% |
| Jun 30, 2019 | 23.44% |
| Mar 31, 2019 | 13.49% |
| Dec 31, 2018 | 11.12% |
| Sep 30, 2018 | -4.03% |
| Jun 30, 2018 | -9.62% |
| Mar 31, 2018 | 8.08% |
| Dec 31, 2017 | 4.98% |
| Sep 30, 2017 | 20.92% |
| Jun 30, 2017 | 39.98% |
| Sep 30, 2016 | 13.81% |
| Jun 30, 2016 | 135.48% |
| Mar 31, 2016 | 22.87% |
| Dec 31, 2015 | -6.75% |
| Sep 30, 2015 | 32.43% |
| Jun 30, 2015 | 29.60% |